The epidemiological study of end-stage renal disease among patients admitted to hemodialysis wards of Ayatollah Taleghani and Imam Khomeini hospitals in Urmia city of Iran, in the 2020's second half

Solahae Kahnamouii , Bita; Mivefroshan, Azam; Ravanyar, Leila; Hosseini, Rana

doi:10.52547/hsm.2.2.73

Volume 2, Issue 2 (April 2023) Health Science Monitor 2023, 2(2): 73-79 | Back to browse issues page

‎ 10.52547/hsm.2.2.73

Mendeley

Zotero

RefWorks

Solahae Kahnamouii B, Mivefroshan A, Ravanyar L, Hosseini R. The epidemiological study of end-stage renal disease among patients admitted to hemodialysis wards of Ayatollah Taleghani and Imam Khomeini hospitals in Urmia city of Iran, in the 2020's second half. Health Science Monitor 2023; 2 (2) :73-79
URL: http://hsm.umsu.ac.ir/article-1-56-en.html

The epidemiological study of end-stage renal disease among patients admitted to hemodialysis wards of Ayatollah Taleghani and Imam Khomeini hospitals in Urmia city of Iran, in the 2020's second half

Bita Solahae Kahnamouii

, Azam Mivefroshan

, Leila Ravanyar

, Rana Hosseini ^*

Social Determinant of Health Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran

Abstract: (1517 Views)

Background & Aims: Chronic kidney disease (CKD), mainly its final stage, known as end-stage renal disease (ESRD), is one of the major challenges for the healthcare system in Iran, and deserves more reflections. Against this background, the present study aimed to elucidate the epidemiology of ESRD among the patients, undergoing permanent treatment, admitted to the hemodialysis (HD) wards of the selected hospitals in Urmia, Iran.
Materials & Methods: In this descriptive-analytical study, using the census method for sampling, we investigated patients experiencing permanent treatment and admitted to the HD wards of the selected hospitals in Urmia, Iran, from October 2020 to March 2021. The criteria for entering the study are the availability of medical record and ESRD cases. On the other hand, the cases receiving intermittent HD were excluded. Furthermore, a checklist was utilized to collect the required data.
Results: The ESRD patients' mean age was 60.63. Also, 59.6% of the cases were male, and the rest (40.4%) was female. Besides, 54.7% of these patients had degrees below high school diplomas, and 72.8% was living in urban areas. The most frequently occurring blood type was O, and the majority of the patients were the Rhesus positive. The average level of serum creatinine was also 20.7 mg/dL. Moreover, the most common underlying diseases were hypertension (HTN) and diabetes mellitus (DM), respectively.
Conclusion: The study findings revealed that monitoring and controlling chronic diseases, such as HTN and DM, as well as raising more awareness among the patients with low literacy, could significantly contribute to managing CKD and its progress.

Keywords: Chronic Kidney Disease, End-Stage Renal Disease, Epidemiology, Hemodialysis

Full-Text [PDF 238 kb] (1076 Downloads)

Type of Study: Research | Subject: Special
Received: 2022/08/15 | Accepted: 2023/02/19 | Published: 2023/04/21

References

1. Murtagh FE, Glassock R. Symptoms in end-stage renal disease. Adv Chronic Kidney Dis. 2007 Jan;14(1):82-99. [DOI] [PMID]

2. Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, et al. Chronic kidney disease. Nat Rev Dis Primers. 2017 Nov 23;3(1):17088. [DOI] [PMID]

3. Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney Disease: improving global outcomes CKD workgroup. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl (2011). 2013 Jan;3(1):1-150. [Google Scholar]

4. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013 Jul 20;382(9888):260-72. [DOI] [PMID]

5. Stanifer JW, Kilonzo K, Wang D, Su G, Mao W, Zhang L. Traditional medicines and kidney disease in low-and middle-income countries: opportunities and challenges. Semin Nephrol. 2017 Mar;37(3):245-59. [DOI] [PMID]

6. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007 Jan;14(1):82-99. [DOI] [PMID]

7. Kusiak A, Dixon B, Shah S. Predicting survival time for kidney dialysis patients: a data mining approach. Comput Biol Med. 2005 Apr;35(4):311-27. [DOI] [PMID]

8. Rosenberg M, Hsu C. Chronic kidney disease and progression. Int J Biol Sci. 2004;3(6):304-8. [URL]

9. Reynolds K, Gu D, Muntner P, Chen J, Wu X, Yau CL, et al. Body mass index and risk of ESRD in China. Am J Kidney Dis. 2007 Nov;50(5):754-64. [DOI] [PMID]

10. Hsu C-y, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009 Feb 23;169(4):342-50. [DOI] [PMID] [PMCID]

11. Stats F, Azar G. National chronic kidney disease fact sheet. World Appl Sci J. 2017;21(5):755-61. [URL]

12. Afshar R, Sanavi S, Salimi J. Epidemiology of chronic renal failure in Iran: a four-year single-center experience. Saudi J Kidney Dis Transpl. 2007 Apr;18(2):191-6. [Google Scholar]

13. Nakai S, Shinzato T, Sanaka T, Kikuchi K, Kitaoka T, Shinoda T, et al. The current state of chronic dialysis treatment. Int J Artif Organs. 2002 Jul;35(7):1155-84. [DOI]

14. Khajehdehi P, Malekmakan L, Pakfetrat M, Roozbeh J, Sayadi M. Prevalence of chronic kidney disease and its contributing risk factors in southern Iran: a cross-sectional adult population-based study. Iran J Kidney Dis. 2014 Mar;8(2):109-20. [Google Scholar]

15. Hadian B, Anbari K, Heidari R. Epidemiologic study of end-stage renal disease and related risk factors in patients under hemodialysis in Lorestan province. Iran Red Crescent Med J. 2015 Mar;16(3):e14451. [URL]

16. Alipour A, Shokri A, Yasari F, Khodakarim S. Introduction to Competing Risk Model in the Epidemiological Research. Int J Epidemiol Res. 2018;5(3):98-102. [DOI]

17. Siddappa JK, Singla S, Mohammed Al Ameen S, Kumar N. Correlation of ultrasonographic parameters with serum creatinine in chronic kidney disease. J Clin Imaging Sci. 2013;3:52. [DOI] [PMID] [PMCID]

18. Alsuwaida AO, Farag YM, Al Sayyari AA, Mousa D, Alhejaili F, Al-Harbi A, et al. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators)-a pilot study. Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1066-78. [Google Scholar]

19. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003 Dec;14(12):131-8. [DOI] [PMID]

20. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol. 2007 Oct;18(10):2644-8. [DOI] [PMID]

21. Monfared A, Safaei A, Panahandeh Z, Nemati L. Incidence of end-stage renal disease in Guilan Province, Iran, 2005 to 2007. Iran J Public Health. 2009;10(2):20-6. [Google Scholar]

22. Malekmakan L, Haghpanah S, Pakfetrat M, Malekmakan A, Khajehdehi P. Causes of chronic renal failure among Iranian hemodialysis patients. Saudi J Kidney Dis Transpl. 2009;20(3):501-510. [Google Scholar]

23. Nafar M, Mousavi SM, Mahdavi M, Firouzan A. Burden of chronic kidney disease in Iran a screening program is of essential need. Int J Epidemiol Res. 2008;12(5):45-52. [Google Scholar]

24. Thomas PP. Changing profile of causes of chronic renal failure. Saudi J Kidney Dis Transpl. 2003;14(4):456-70 [Google Scholar]